瑞普生物：公司重点实施三大关键举措推动原料药板块提质增效

Core Insights - The company announced three key initiatives to enhance the quality and efficiency of its API (Active Pharmaceutical Ingredient) segment [1] Group 1: Cost Reduction - The company aims to deepen lean cost reduction by optimizing production processes and enhancing centralized procurement management to effectively lower unit production costs [1] Group 2: Market Expansion - The company plans to accelerate its overseas market expansion and continue to increase its export share [1] Group 3: Product Optimization - The company intends to optimize its product structure by increasing the proportion of high-margin products, with plans to launch new products such as hydrochloride vonoprazan dihydrate and cefotaxime crystals in the second half of the year to enrich its high-value product matrix and improve overall profitability [1]